How much should you hold?
- Overall Portfolio exposure to Shedir Pharma Group SpA should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals: Other should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals: Other)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
No Data Found
Quality key factors
Factor
Value
Sales Growth (5y)
4.70%
EBIT Growth (5y)
0.94%
EBIT to Interest (avg)
6.71
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
1.36
Tax Ratio
29.06%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
30.23%
ROE (avg)
15.70%
Valuation Key Factors 
Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
1.48
EV to EBIT
5.24
EV to EBITDA
3.64
EV to Capital Employed
1.66
EV to Sales
0.75
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
31.60%
ROE (Latest)
16.21%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Bullish
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Shedir Pharma Group SpA
Raw Material Cost
Fallen by -7.58% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Shedir Pharma Group SpA
Inventory Turnover Ratio
Lowest at 1.71%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio






